Literature DB >> 8672020

Malignant hypertension in children in India.

P Kumar1, P Arora, V Kher, P K Rai, S Gulati, S S Baijal, S Kumar.   

Abstract

BACKGROUND: Malignant hypertension is now an uncommon entity in the western world but still remains a significant problem in India. Therefore we studied the aetiological spectrum, management, and outcome of these patients.
METHODS: Forty consecutive children (<16 years) with malignant hypertension were admitted and investigated to exclude or confirm the secondary causes of hypertension. For acute control of blood pressure sublingual nifedipine was used in dosage of 0.3-0.6 mg/kg, failing which intravenous nitroglycerin was used. In patients with aortoarteritis with active disease, steroids were used. Angioplasty was carried out for renal artery stenosis whenever possible.
RESULTS: Renoparenchymal disease was the commonest cause of malignant hypertension, and was seen in 25 cases, renovascular hypertension in 13 cases (11 aortoarteritis and two fibromuscular dysplasia) and two had essential hypertension. For acute control of severe hypertension, sublingual nifedipine was effective in 92.5% of patients. Of the patients with renoparenchymal disease five became normotensive with treatment of the underlying disease, four received renal allograft, seven died, and nine are stable on antihypertensive drugs. Renal angioplasty was carried out in seven patients with renovascular hypertension (4 cured, 3 improved) and six are controlled on drugs.
CONCLUSIONS: We conclude that apart from renoparenchymal disease, aortoarteritis is a common cause of malignant hypertension in children. Sublingual nifedipine is effective for the rapid control of severe hypertension, and angioplasty is effective in aortoarteritis for short-term preservation of renal function and control of hypertension.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8672020

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  9 in total

Review 1.  Renovascular hypertension--is it fibromuscular dysplasia or Takayasu arteritis.

Authors:  Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2012-03-28       Impact factor: 3.714

2.  Management of the renovascular disease in children with Takayasu arteritis.

Authors:  Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2015-05-16       Impact factor: 3.714

Review 3.  Management of hypertension emergencies.

Authors:  William J Elliott
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

4.  Captopril-enhanced renal scintigraphy in the diagnosis of pediatric hypertension.

Authors:  György Sandor Reusz; Eva Kis; Orsolya Cseprekál; Attila Jozsef Szabó; Eva Kis
Journal:  Pediatr Nephrol       Date:  2009-10-20       Impact factor: 3.714

Review 5.  Hypertension in children.

Authors:  Sanjeev Gulati
Journal:  Indian J Pediatr       Date:  2002-12       Impact factor: 1.967

6.  Pediatric renovascular hypertension in Thailand: CT angiographic findings.

Authors:  Pannee Visrutaratna; Tanop Srisuwan; Chusak Sirivanichai
Journal:  Pediatr Radiol       Date:  2009-08-14

Review 7.  Treatment of severe renal artery stenosis by percutaneous transluminal renal angioplasty and stent implantation: review of the pediatric experience: apropos of two cases.

Authors:  Kai König; Jutta Gellermann; Uwe Querfeld; Martin B E Schneider
Journal:  Pediatr Nephrol       Date:  2006-03-07       Impact factor: 3.714

Review 8.  Renovascular hypertension in pediatric patients: update on diagnosis and management.

Authors:  Juliana Lacerda de Oliveira Campos; Letícia Bitencourt; Ana Luisa Pedrosa; Diego Ferreira Silva; Filipe Ji Jen Lin; Lucas Teixeira de Oliveira Dias; Ana Cristina Simões E Silva
Journal:  Pediatr Nephrol       Date:  2021-04-13       Impact factor: 3.714

9.  Validation of computed tomography angiography as a complementary test in the assessment of renal artery stenosis: a comparison with digital subtraction angiography.

Authors:  Anilawan S Fleury; Rachelle E Durand; Anne Marie Cahill; Xiaowei Zhu; Kevin E Meyers; Hansel J Otero
Journal:  Pediatr Radiol       Date:  2021-08-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.